Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety

Author

S. Dell'Aniello

Keywords

Administration, Inhalation

Adrenal Cortex Hormones/therapeutic use

Adrenergic beta-2 Receptor Agonists/therapeutic use

Bronchodilator Agents

Budesonide/adverse effects

Fluticasone/therapeutic use

*Pneumonia/epidemiology/etiology

*Pulmonary Disease, Chronic Obstructive

COPD exacerbations

New-user cohort design

inhaled corticosteroids

long-acting bronchodilators

observational research

real-world evidence

Year of Publication

2022

Journal

Copd

Volume

19

Number of Pages

109-117

ISBN Number

1541-2563

Accession Number

35385359

DOI

10.1080/15412555.2022.2035705